Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Hepatitis A virus transmission by blood products in the United States. Transfusion Safety Study Group.

Mosley JW, Nowicki MJ, Kasper CK, Donegan E, Aledort LM, Hilgartner MW, Operskalski EA.

Vox Sang. 1994;67 Suppl 1:24-8.

PMID:
8091731
2.
3.

Haemophilia care in Zimbabwe.

Adewuyi JO, Coutts AM, Levy L, Lloyd SE.

Cent Afr J Med. 1996 May;42(5):153-6. Review.

PMID:
8771937
4.

Sequence variability of hepatitis A virus and factor VIII associated hepatitis A infections in hemophilia patients in Europe. An update.

Robertson BH, Friedberg D, Normann A, Graff J, Flehmig B, Shouval D.

Vox Sang. 1994;67 Suppl 1:39-45; discussion 46. Review.

PMID:
8091736
5.

Hepatitis A virus sequence detected in clotting factor concentrates associated with disease transmission.

Robertson BH, Alter MJ, Bell BP, Evatt B, McCaustland KA, Shapiro CN, Sinha SD, Souci JM.

Biologicals. 1998 Jun;26(2):95-9. Review.

PMID:
9811512
6.
7.

Removal and inactivation of hepatitis A virus (HAV) during processing of factor VIII concentrates.

Hamman J, Zou J, Horowitz B.

Vox Sang. 1994;67 Suppl 1:72-6; discussion 77. Review.

PMID:
8091742
8.

Viral safety of solvent-detergent treated blood products.

Horowitz B, Prince AM, Horowitz MS, Watklevicz C.

Dev Biol Stand. 1993;81:147-61. Review.

PMID:
8174797
9.

Safety of plasma derivatives.

Ingerslev J.

Haemostasis. 1994 Sep-Oct;24(5):311-23. Review.

PMID:
7843643
10.

FDA perspective on and response to the risk of hepatitis A from blood products.

Fricke W.

Vox Sang. 1994;67 Suppl 4:16-8; discussion 24-6. Review.

PMID:
7831864
11.

Risk of hepatitis A virus infection in persons with hemophilia receiving plasma-derived products.

Richardson LC, Evatt BL.

Transfus Med Rev. 2000 Jan;14(1):64-73. Review. No abstract available.

PMID:
10669941
Items per page

Supplemental Content

Write to the Help Desk